Deletion of Ubiquitin Fold Modifier Protein Ufm1 Processing Peptidase Ufsp in L. donovani Abolishes Ufm1 Processing and Alters Pathogenesis

• Sreenivas Gannavaram ,

  * E-mail: sreenivas.gannavaram@fda.hhs.gov (SG); hira.nakhasi@fda.hhs.gov (HLN)

  Affiliation Laboratory of Emerging Pathogens, Division of Emerging and Transfusion Transmitted Diseases, Center for Biologics Evaluation and Research, FDA, Bethesda, Maryland, United States of America

  ⨯
• Sonya Davey,

  Current address: University of Pennsylvania, Philadelphia, Pennsylvania, United States of America.

  Affiliation Laboratory of Emerging Pathogens, Division of Emerging and Transfusion Transmitted Diseases, Center for Biologics Evaluation and Research, FDA, Bethesda, Maryland, United States of America

  ⨯
• Ines Lakhal-Naouar,

  Affiliation Laboratory of Emerging Pathogens, Division of Emerging and Transfusion Transmitted Diseases, Center for Biologics Evaluation and Research, FDA, Bethesda, Maryland, United States of America

  ⨯
• Robert Duncan,

  Affiliation Laboratory of Emerging Pathogens, Division of Emerging and Transfusion Transmitted Diseases, Center for Biologics Evaluation and Research, FDA, Bethesda, Maryland, United States of America

  ⨯
• Hira L. Nakhasi

  * E-mail: sreenivas.gannavaram@fda.hhs.gov (SG); hira.nakhasi@fda.hhs.gov (HLN)

  Affiliation Laboratory of Emerging Pathogens, Division of Emerging and Transfusion Transmitted Diseases, Center for Biologics Evaluation and Research, FDA, Bethesda, Maryland, United States of America

  ⨯